Why Axsome Therapeutics Stock Is Rising Today
Portfolio Pulse from Ryan Gustafson
Axsome Therapeutics (NASDAQ:AXSM) shares are trading higher following a recent corporate presentation where the company provided peak sales estimates for drugs in its portfolio. Mizuho analyst Graig Suvannavejh reiterated a Buy rating and maintained a $95 price target, while Morgan Stanley analyst Vikram Purohit maintained an Equal-Weight rating and raised the price target from $87 to $90.
June 14, 2023 | 7:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Axsome Therapeutics shares are up following a corporate presentation and positive analyst ratings from Mizuho and Morgan Stanley.
The stock price of Axsome Therapeutics is likely to go up in the short term due to the positive analyst ratings from Mizuho and Morgan Stanley, as well as the company's recent corporate presentation where they provided peak sales estimates for drugs in their portfolio. These factors contribute to increased investor confidence and interest in the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100